Operationalizing a Breakthrough Bladder Cancer Medication With a Multidisciplinary Approach: Insights From Nurse Leaders
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Non–muscle-invasive bladder cancer is one of the most common forms of bladder cancer in the United States. Roughly 75% of bladder cancer cases are classified as non–muscle-invasive at diagnosis. 1 According to the American Cancer Society, bladder cancer is the fourth most common cancer in the US, with an estimated 83,190 new cases diagnosed in 2023 (about 63,070 in men and 20,120 in women). 2 While
